Screener
Nektar Therapeutics NKTR Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|---|---|---|---|
| General and administrative | 13,439 | 24,346 | |
| Restructuring and impairment | 796 | 169 | |
| Total operating costs and expenses | 49,915 | 54,995 | |
| Loss from operations | (39,054) | (44,535) | |
| Non-operating income (expense): | |||
| Non-cash interest expense on liabilities related to the sales of future royalties | (7,942) | (4,974) | |
| Interest income | 4,242 | 2,874 | |
| Other income (expense), net (including income of $2 and $321 for the three months ended March 31, 2026 and 2025, respectively, from a related party) | (336) | 266 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's operating income?
- Nektar Therapeutics (NKTR) reported operating income of -$39.05M in Q1 2026.
- How has Nektar Therapeutics's operating income changed year-over-year?
- Nektar Therapeutics's operating income increased by 12.3% year-over-year, from -$44.54M to -$39.05M.
- What is the long-term trend for Nektar Therapeutics's operating income?
- Over 3 years (2021 to 2025), Nektar Therapeutics's operating income has grown at a -32.0% compound annual growth rate (CAGR), from -$446.1M to -$140.1M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Nektar Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude